Search research articles
Contact Us
Filters
Showing results (911-920 of 945) with videos related to
Page
of 95
Sort By:
The Journal of Clinical Investigation
|
April 8, 2020
Deployment of convalescent plasma for the prevention and treatment of COVID-19
Evan M Bloch, Shmuel Shoham, Arturo Casadevall, et al.
The Oncologist
|
May 27, 2020
Phase I Study of Veliparib on an Intermittent and Continuous Schedule in Combination with Carboplatin in Metastatic Breast Cancer: A Safety and [18F]-Fluorothymidine Positron Emission Tomography Biomarker Study
Robert Wesolowski, Daniel G Stover, Maryam B Lustberg, et al.
JCI Insight
|
November 8, 2024
Inhibition of Bruton's tyrosine kinase with PD-1 blockade modulates T cell activation in solid tumors
Emily Schwarz, Brooke Benner, Robert Wesolowski, et al.
Frontiers in Public Health
|
October 12, 2020
Study Protocol: A Cross-Sectional Examination of Socio-Demographic and Ecological Determinants of Nutrition and Disease Across Madagascar
Christopher D Golden, Benjamin L Rice, Hervet J Randriamady, et al.
Journal of Medicinal Chemistry
|
October 17, 2003
Nonpeptide alphavbeta3 antagonists. 8. In vitro and in vivo evaluation of a potent alphavbeta3 antagonist for the prevention and treatment of osteoporosis
John H Hutchinson, Wasyl Halczenko, Karen M Brashear, et al.
Elife
|
April 3, 2019
Mapping imported malaria in Bangladesh using parasite genetic and human mobility data
Hsiao-Han Chang, Amy Wesolowski, Ipsita Sinha, et al.
PLOS Global Public Health
|
May 29, 2026
Target product profiles of laboratory and data analytical frameworks for genotyping to monitor antimalarial efficacy
Mateusz M Plucinski, Amy Wesolowski, Inna Gerlovina, et al.
Brain, Behavior, and Immunity
|
June 1, 2024
Chemotherapy-induced gut microbiome disruption, inflammation, and cognitive decline in female patients with breast cancer
L D Otto-Dobos, C V Grant, A A Lahoud, et al.
NPJ Breast Cancer
|
December 30, 2022
A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013
Foluso O Ademuyiwa, Feng Gao, Cherease R Street, et al.
Journal of Medicinal Chemistry
|
September 19, 2019
Identification of CNS-Penetrant Aryl Sulfonamides as Isoform-Selective Na<sub>V</sub>1.6 Inhibitors with Efficacy in Mouse Models of Epilepsy
Thilo Focken, Kristen Burford, Michael E Grimwood, et al.
Page
of 95
Search research articles
Search
Showing results (911-920 of 945) with videos related to
Sort By:
Page
of 95
The Journal of Clinical Investigation
|
April 8, 2020
Deployment of convalescent plasma for the prevention and treatment of COVID-19
Evan M Bloch, Shmuel Shoham, Arturo Casadevall, et al.
The Oncologist
|
May 27, 2020
Phase I Study of Veliparib on an Intermittent and Continuous Schedule in Combination with Carboplatin in Metastatic Breast Cancer: A Safety and [18F]-Fluorothymidine Positron Emission Tomography Biomarker Study
Robert Wesolowski, Daniel G Stover, Maryam B Lustberg, et al.
JCI Insight
|
November 8, 2024
Inhibition of Bruton's tyrosine kinase with PD-1 blockade modulates T cell activation in solid tumors
Emily Schwarz, Brooke Benner, Robert Wesolowski, et al.
Frontiers in Public Health
|
October 12, 2020
Study Protocol: A Cross-Sectional Examination of Socio-Demographic and Ecological Determinants of Nutrition and Disease Across Madagascar
Christopher D Golden, Benjamin L Rice, Hervet J Randriamady, et al.
Journal of Medicinal Chemistry
|
October 17, 2003
Nonpeptide alphavbeta3 antagonists. 8. In vitro and in vivo evaluation of a potent alphavbeta3 antagonist for the prevention and treatment of osteoporosis
John H Hutchinson, Wasyl Halczenko, Karen M Brashear, et al.
Elife
|
April 3, 2019
Mapping imported malaria in Bangladesh using parasite genetic and human mobility data
Hsiao-Han Chang, Amy Wesolowski, Ipsita Sinha, et al.
PLOS Global Public Health
|
May 29, 2026
Target product profiles of laboratory and data analytical frameworks for genotyping to monitor antimalarial efficacy
Mateusz M Plucinski, Amy Wesolowski, Inna Gerlovina, et al.
Brain, Behavior, and Immunity
|
June 1, 2024
Chemotherapy-induced gut microbiome disruption, inflammation, and cognitive decline in female patients with breast cancer
L D Otto-Dobos, C V Grant, A A Lahoud, et al.
NPJ Breast Cancer
|
December 30, 2022
A randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013
Foluso O Ademuyiwa, Feng Gao, Cherease R Street, et al.
Journal of Medicinal Chemistry
|
September 19, 2019
Identification of CNS-Penetrant Aryl Sulfonamides as Isoform-Selective Na<sub>V</sub>1.6 Inhibitors with Efficacy in Mouse Models of Epilepsy
Thilo Focken, Kristen Burford, Michael E Grimwood, et al.
Page
of 95